 This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: 1 Patients diagnosed with ENKTL, nasal type between January 1, 1995 and December 31, 2014; 2 Patients treated with non-anthracycline based therapy as an initial treatment. The pathology of initial diagnosis was reviewed by designated pathologists. 